Neonc Technologies Holdings, Inc. (NTHI) Stock Analysis & Investment Frameworks
Neonc Technologies Holdings, Inc. (NTHI) stock analysis on Invetso. Review Neonc Technologies Holdings, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Neonc Technologies Holdings, Inc. Company Overview
- Exchange: NASDAQ Global Select
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
Neonc Technologies Holdings, Inc. Key Financial Metrics
- Market Cap: $77.77M
- Revenue: $39990.00
- ROE: 309.09%
- ROIC: 229.42%
- Dividend Yield: N/A
About Neonc Technologies Holdings, Inc.
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.
Neonc Technologies Holdings, Inc. Investment Frameworks
Invetso analyzes Neonc Technologies Holdings, Inc. (NTHI) across the following frameworks:
- Neonc Technologies Holdings, Inc. 10Y Growth Potential
- Neonc Technologies Holdings, Inc. Scenario Analysis
- Neonc Technologies Holdings, Inc. Risks & Opportunities
- Neonc Technologies Holdings, Inc. Economic Moat
- Neonc Technologies Holdings, Inc. Business Model
- Neonc Technologies Holdings, Inc. Management
- Neonc Technologies Holdings, Inc. SWOT Analysis
- Neonc Technologies Holdings, Inc. Porter's 5 Forces
- Neonc Technologies Holdings, Inc. PESTLE Analysis
- Neonc Technologies Holdings, Inc. ESG Analysis